Treatment with the experimental medication eflornithine in combination with the approved chemotherapy Gleostine (lomustine) may help improve survival in people…
Articles by Marisa Wexler, MS
Dosing has begun in a Phase 3 clinical trial testing Enhertu (trastuzumab deruxtecan) as a maintenance treatment for certain people…
Most people with hard-to-treat myeloma were still alive and free from disease progression two years after treatment with anito-cel…
The U.S. Food and Drug Administration (FDA) has granted fast track designation to the experimental medicine CLN-049, which is being…
The U.S. Food and Drug Administration (FDA) has granted fast track status to zotiraciclib (ZTR/TG02) — an oral medication that…
A new experimental therapy, DT2216, has begun testing in a clinical trial for people with hard-to-treat ovarian cancer, a significant…
Most myeloma patients who started treatment at the Berenson Cancer Center — a clinic in California that specializes…
The Ovarian Cancer Research Alliance (OCRA) launched a project to push lawmakers to enact legislation that will improve the…
Mission Bio has debuted a new laboratory test that enables researchers to simultaneously detect alterations in the genetic code…
Changes in how cells respond to the hormone estrogen may underlie the development of certain forms of pancreatic cancer.